Skip to main content
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
6.30
-0.08 (-1.25%)
At close: Mar 9, 2026, 4:00 PM EDT
6.25
-0.05 (-0.79%)
After-hours: Mar 9, 2026, 6:56 PM EDT

Verastem Revenue

In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth. Verastem had revenue of $17.54M in the quarter ending December 31, 2025.

Revenue (ttm)
$30.91M
Revenue Growth
+209.14%
P/S Ratio
17.90
Revenue / Employee
$396,333
Employees
78
Market Cap
553.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 294.28M
Fulcrum Therapeutics 80.00M
MeiraGTx Holdings 27.42M
Ocugen 4.41M
YD Bio 510.36K
Revenue Rankings

VSTM News

More News